Genetic analysis of glutathione S-transferase A1 and T1 polymorphisms in a Japanese population

Verfasser / Beitragende:
[Kumi Matsuno, Takahiro Kubota, Yuji Matsukura, Hiroshi Ishikawa, Tatsuji Iga]
Ort, Verlag, Jahr:
2004
Enthalten in:
Clinical Chemistry and Laboratory Medicine, 42/5(2004-05-10), 560-562
Format:
Artikel (online)
ID: 378892207
LEADER caa a22 4500
001 378892207
003 CHVBK
005 20180305123457.0
007 cr unu---uuuuu
008 161128e20040510xx s 000 0 eng
024 7 0 |a 10.1515/CCLM.2004.095  |2 doi 
035 |a (NATIONALLICENCE)gruyter-10.1515/CCLM.2004.095 
245 0 0 |a Genetic analysis of glutathione S-transferase A1 and T1 polymorphisms in a Japanese population  |h [Elektronische Daten]  |c [Kumi Matsuno, Takahiro Kubota, Yuji Matsukura, Hiroshi Ishikawa, Tatsuji Iga] 
520 3 |a Novel allelic variants have been found in the glutathione S-transferase (GST) A1 and T1 genes. The former GSTA1*B allele is associated with low expression and the latter GSTT1*B allele lacks GSTT1 activity. The information on frequencies of both variants is poorly documented in the Japanese population. In this study we determined the frequencies of allelic variants of GSTA1 and GSTT1 in a Japanese population using PCR-restriction fragment length polymorphism and allele-specific PCR. The frequencies of GSTA1*B, GSTT1*0 and GSTT1*B alleles in the subjects were 16.0%, 71.1% and 0%, respectively. This is the first report on the frequencies of allelic variants of GSTA1 and GSTT1 in a Japanese population. 
540 |a Copyright © 2004 by Walter de Gruyter GmbH & Co. KG 
690 7 |a Medical equipment & techniques  |2 nationallicence 
690 7 |a Medical diagnosis  |2 nationallicence 
690 7 |a Diseases & disorders  |2 nationallicence 
700 1 |a Matsuno  |D Kumi  |4 aut 
700 1 |a Kubota  |D Takahiro  |4 aut 
700 1 |a Matsukura  |D Yuji  |4 aut 
700 1 |a Ishikawa  |D Hiroshi  |4 aut 
700 1 |a Iga  |D Tatsuji  |4 aut 
773 0 |t Clinical Chemistry and Laboratory Medicine  |d Walter de Gruyter  |g 42/5(2004-05-10), 560-562  |x 1434-6621  |q 42:5<560  |1 2004  |2 42  |o cclm 
856 4 0 |u https://doi.org/10.1515/CCLM.2004.095  |q text/html  |z Onlinezugriff via DOI 
908 |D 1  |a research article  |2 jats 
950 |B NATIONALLICENCE  |P 856  |E 40  |u https://doi.org/10.1515/CCLM.2004.095  |q text/html  |z Onlinezugriff via DOI 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Matsuno  |D Kumi  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Kubota  |D Takahiro  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Matsukura  |D Yuji  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Ishikawa  |D Hiroshi  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Iga  |D Tatsuji  |4 aut 
950 |B NATIONALLICENCE  |P 773  |E 0-  |t Clinical Chemistry and Laboratory Medicine  |d Walter de Gruyter  |g 42/5(2004-05-10), 560-562  |x 1434-6621  |q 42:5<560  |1 2004  |2 42  |o cclm 
900 7 |b CC0  |u http://creativecommons.org/publicdomain/zero/1.0  |2 nationallicence 
898 |a BK010053  |b XK010053  |c XK010000 
949 |B NATIONALLICENCE  |F NATIONALLICENCE  |b NL-gruyter